1. Home
  2. BDTX vs JJSF Comparison

BDTX vs JJSF Comparison

Compare BDTX & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • JJSF
  • Stock Information
  • Founded
  • BDTX 2014
  • JJSF 1971
  • Country
  • BDTX United States
  • JJSF United States
  • Employees
  • BDTX N/A
  • JJSF N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • JJSF Specialty Foods
  • Sector
  • BDTX Health Care
  • JJSF Consumer Staples
  • Exchange
  • BDTX Nasdaq
  • JJSF Nasdaq
  • Market Cap
  • BDTX 181.4M
  • JJSF 2.1B
  • IPO Year
  • BDTX 2020
  • JJSF N/A
  • Fundamental
  • Price
  • BDTX $3.16
  • JJSF $101.70
  • Analyst Decision
  • BDTX Strong Buy
  • JJSF Buy
  • Analyst Count
  • BDTX 6
  • JJSF 2
  • Target Price
  • BDTX $12.50
  • JJSF $142.50
  • AVG Volume (30 Days)
  • BDTX 840.0K
  • JJSF 127.4K
  • Earning Date
  • BDTX 11-04-2025
  • JJSF 11-12-2025
  • Dividend Yield
  • BDTX N/A
  • JJSF 3.06%
  • EPS Growth
  • BDTX N/A
  • JJSF N/A
  • EPS
  • BDTX 0.25
  • JJSF 4.29
  • Revenue
  • BDTX $70,000,000.00
  • JJSF $1,599,746,000.00
  • Revenue This Year
  • BDTX N/A
  • JJSF $3.57
  • Revenue Next Year
  • BDTX N/A
  • JJSF $2.70
  • P/E Ratio
  • BDTX $12.78
  • JJSF $23.79
  • Revenue Growth
  • BDTX N/A
  • JJSF 0.49
  • 52 Week Low
  • BDTX $1.20
  • JJSF $101.50
  • 52 Week High
  • BDTX $6.23
  • JJSF $180.80
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 58.90
  • JJSF 30.36
  • Support Level
  • BDTX $3.13
  • JJSF $101.50
  • Resistance Level
  • BDTX $3.43
  • JJSF $108.56
  • Average True Range (ATR)
  • BDTX 0.18
  • JJSF 2.48
  • MACD
  • BDTX 0.02
  • JJSF -0.72
  • Stochastic Oscillator
  • BDTX 63.51
  • JJSF 1.61

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

Share on Social Networks: